1. Home
  2. OOMA vs STRO Comparison

OOMA vs STRO Comparison

Compare OOMA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$11.17

Market Cap

343.1M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.66

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
STRO
Founded
2003
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
343.1M
85.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
OOMA
STRO
Price
$11.17
$10.66
Analyst Decision
Strong Buy
Hold
Analyst Count
3
8
Target Price
$19.00
$18.29
AVG Volume (30 Days)
296.1K
115.4K
Earning Date
12-08-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$264,115,000.00
$105,646,000.00
Revenue This Year
$7.29
$63.08
Revenue Next Year
$17.91
N/A
P/E Ratio
$136.81
N/A
Revenue Growth
4.22
N/A
52 Week Low
$9.79
$5.23
52 Week High
$15.65
$21.50

Technical Indicators

Market Signals
Indicator
OOMA
STRO
Relative Strength Index (RSI) 45.57 71.68
Support Level $11.19 $8.49
Resistance Level $11.78 $12.18
Average True Range (ATR) 0.46 0.85
MACD -0.02 -0.12
Stochastic Oscillator 3.81 65.63

Price Performance

Historical Comparison
OOMA
STRO

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: